Ukuxhalabisa kunye neBupar
I-BuSpar (buspirone hydrochloride) isetyenziselwa ukuphatha iingxaki zokuxhalabisa kunye nexesha elifutshane lokukhulula ekuxhatheni. I-BuSpar ayinxulumene nekhemikhali okanye i-pharmacologically kwezinye iyeza zokuxhalabisa ezinjenge-benzodiazepines okanye ezinye izidalwa. Ukusebenza kwe-BuSpar yokunyangwa kwengxaki yokukhathazeka jikelele (GAD) isungulwe.
I-Bristol-Meyers Squibb yafumana imvume kwi-Food and Drug Administration (FDA) ngo-1986 ukusetyenziswa kwebhasipirone (igama lezorhwebo eBurpar) elisetyenziswe kunyango lwe-GAD.
Nangona kunjalo, i-patent yaphela ngo-2001 kwaye i-buspirone ithengiswa njengesiyobisi.
Indlela yokuSebenza
I-Buspirone ivela kwiklasi ye-azaspirone yamachiza kunye nemiphumo kwi-serotonin yokuthunyelwa kunye ne-noradrenergic kunye ne-dopaminergic.
Indlela yokuthatha i-BuSpar
Iipilisi zeBupar kufuneka zithathwe ngokuqhelekileyo ngokutya okanye ngaphandle. Ngokuqhelekileyo kuthathwa kabini okanye kathathu imihla ngemihla.
Izikhokelo zeNqanaba
I-dose yokuqala ephakanyisiweyo yeBupar i-5 mg kabini imihla ngemihla. Umthamo unganyuswa ngo-5 mg nganye iintsuku ezimbini ukuya kwezi-3, kunye nomthamo omkhulu ongadluli kwi-60 mg.
Ngubani ongafanelanga ukuthatha i-BuSpar
I-Buspar (buspirone hydrochloride) akufanele ithatyathwe ngabantu abanomdla kwiziyobisi, kwaye kufuneka isetyenziswe ngokubhekisele kumsebenzi wesibindi okanye iimeko zonyango ezikhoyo.
Ulwalamano lweMithi
I-BuSpar iyakwazi ukusebenzisana namayeza amaninzi kuquka i- monoamine oxidase inhibitors (MAOIs) .
Kubalulekile ukuba ugqirha wakho uyazi zonke ezinye iyeza ozithathayo ngoku. Ukongezelela, kukulungele ukuphepha ukusebenzisa kotywala ngelixa uthabatha i-BuSpar.
Iziphumo ezimbi
Uluhlu lweempembelelo ezinobungozi lunokwenzeka xa uthabatha i-Buspar, eyona nto ixhaphakileyo, isisonguluko, intloko, ukukhathazeka okanye ukuzonwabisa, kunye nobunzima.
Ezinye iziphumo ezinokuthi zibi zibandakanya oku kulandelayo:
- ukuzela, ukukhathala
- ukuhlanza, ukugulisa isisu, intlungu yesisu
- ukutyunjwa, urhudo
- umlomo owomileyo
- kunzima ukulala
- ubuthathaka, ukunyaniseka
Mngcipheko
Nangona i-BuSpar iyancipha ngakumbi kunamanye amayeza enokuxhalabisa, sebenzisa ukuqwalasela xa uqhuba, usebenzise imishini okanye uthatha inxaxheba kwimisebenzi enobungozi. Kukho umngcipheko wokuxhomekeka kwezinto ezingokwenyama okanye kwengqondo kwi-BuSpar, kwaye umngcipheko wokudlulela ngokweqile uphantsi.
I-BuSpar kunye neNkxalabo yokuXhalabisa kweNtlalo
Olunye uvavanyo oluncinane ukususela ngo-1993 lwabonisa ukuphucula emva kokusetyenziswa kwebhapirone kwisilingo esivulekileyo seveki ezili-12 kunye nezigulane ezili-17 ezinezigulane zentlalo eziqhelekileyo ezisekelwe kwiimfuno ze-DSM-III-R (izigulane ezili-12 zabonisa ukuphucula). Nangona kunjalo, uphando olulawulwa yi-placebo olulawulwa yi-placebo lwangama-30 ezigulane ezine-SAD ngo-1997 aluboniswanga uphuculo oluqhathaniswa ne-placebo.
Ezi ziphumo zibonisa ukuba i-buspirone njengokhetho olulodwa lonyango olungenakunceda ukuphazamiseka kwengxaki yoluntu engahambelani nezinye izifo. Nangona kunjalo, ukuba awuphenduli kwamanye amayeza afana ne-seleotonin reuptake inhibitors (i-SSRIs), i-buspirone ingaba yindlela yokunyusa isicwangciso sakho sokhathalela kwangoku.
Imithombo:
Halaby A, Haddad RS, Naja WJ. Ulwaphulo oluninzi lwengxaki yokuxhatshazwa kwengxaki yokukhathazeka kweNtlalo: Ukuphononongwa. I-Curr Clinic Pharmacol . Fe bruwari 2013.
Schneier FR, Saoud JB, Campeas R, et al. Buspirone kwi-social phobia. J Clin Psychopharmacol . 1993; 13 (4): 251-256.
ILayibrari yeSizwe ka-US yamayeza. Buspirone. Kufumaneke ngoMeyi 24, 2016.
van Vliet IM, den Boer JA, iWestenberg HG, i-Pian KL. Imiphumo yesifo se-buspirone kwi-social phobia: i-studybo-control-controlled controlled study. J Clin Psychiatry . 1997; 58 (4): 164-168.